275 related articles for article (PubMed ID: 18308795)
1. Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa.
Smarius LJ; Jacobs GE; Hoeberechts-Lefrandt DH; de Kam ML; van der Post JP; de Rijk R; van Pelt J; Schoemaker RC; Zitman FG; van Gerven JM; Gijsman HJ
J Psychopharmacol; 2008 Jun; 22(4):426-33. PubMed ID: 18308795
[TBL] [Abstract][Full Text] [Related]
2. Enhanced tolerability of the 5-hydroxytryptophane challenge test combined with granisetron.
Jacobs GE; Kamerling IM; de Kam ML; Derijk RH; van Pelt J; Zitman FG; van Gerven JM
J Psychopharmacol; 2010 Jan; 24(1):65-72. PubMed ID: 18719048
[TBL] [Abstract][Full Text] [Related]
3. Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers.
Gijsman HJ; van Gerven JM; de Kam ML; Schoemaker RC; Pieters MS; Weemaes M; de Rijk R; van der Post J; Cohen AF
J Clin Psychopharmacol; 2002 Apr; 22(2):183-9. PubMed ID: 11910264
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and CNS pharmacodynamics of the 5-HT1A agonist buspirone in humans following acute L-tryptophan depletion challenge.
Jagannathan V; Venitz J
Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):351-62. PubMed ID: 9379784
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamic glutamate levels following serotonergic stimulation: a pilot study using 7-Tesla magnetic resonance spectroscopy in healthy volunteers.
Jacobs GE; der Grond Jv; Teeuwisse WM; Langeveld TJ; van Pelt J; Verhagen JC; de Kam ML; Cohen AF; Zitman FG; van Gerven JM
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):486-91. PubMed ID: 20138102
[TBL] [Abstract][Full Text] [Related]
6. Central serotonergic hypofunction in autism: results of the 5-hydroxy-tryptophan challenge test.
Croonenberghs J; Wauters A; Deboutte D; Verkerk R; Scharpe S; Maes M
Neuro Endocrinol Lett; 2007 Aug; 28(4):449-55. PubMed ID: 17693983
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of l-5-hydroxytryptophan in healthy subjects.
Westenberg HG; Gerritsen TW; Meijer BA; van Praag HM
Psychiatry Res; 1982 Dec; 7(3):373-85. PubMed ID: 6187038
[TBL] [Abstract][Full Text] [Related]
8. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations.
Thal LJ; Sharpless NS; Wolfson L; Katzman R
Ann Neurol; 1980 Jun; 7(6):570-6. PubMed ID: 6969054
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
[TBL] [Abstract][Full Text] [Related]
10. Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.
Algorta J; Pena MA; Alvarez A; Maraschiello C; Maruhn D; Windisch M; Mucke HA
Int J Clin Pharmacol Ther; 2009 Jul; 47(7):483-90. PubMed ID: 19640356
[TBL] [Abstract][Full Text] [Related]
11. First human exposure to exogenous single-dose oral estetrol in early postmenopausal women.
Visser M; Holinka CF; Coelingh Bennink HJ
Climacteric; 2008; 11 Suppl 1():31-40. PubMed ID: 18464021
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, safety, and tolerability of R411, a dual alpha4beta1-alpha4beta7 integrin antagonist after oral administration at single and multiple once-daily ascending doses in healthy volunteers.
Hijazi Y; Welker H; Dorr AE; Tang JP; Blain R; Renzetti LM; Abbas R
J Clin Pharmacol; 2004 Dec; 44(12):1368-78. PubMed ID: 15545307
[TBL] [Abstract][Full Text] [Related]
13. Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life.
Saari TI; Laine K; Leino K; Valtonen M; Neuvonen PJ; Olkkola KT
Clin Pharmacol Ther; 2006 Nov; 80(5):502-8. PubMed ID: 17112806
[TBL] [Abstract][Full Text] [Related]
14. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers.
Maron E; Tõru I; Vasar V; Shlik J
J Psychopharmacol; 2004 Jun; 18(2):194-9. PubMed ID: 15260907
[TBL] [Abstract][Full Text] [Related]
15. Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation.
Saletu B; Barbanoj MJ; Anderer P; Sieghart W; Grünberger J
Methods Find Exp Clin Pharmacol; 1993 Jun; 15(5):291-312. PubMed ID: 8412414
[TBL] [Abstract][Full Text] [Related]
16. Plasma accumulation of metabolism of orally administered single dose L-5-hydroxytryptophan in man.
Magnussen I; Jensen TS; Rand JH; Van Woert MH
Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):184-9. PubMed ID: 6175178
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers.
Zdravkovic M; Søgaard B; Ynddal L; Christiansen T; Agersø H; Thomsen MS; Falch JE; Ilondo MM
Growth Horm IGF Res; 2000 Aug; 10(4):193-8. PubMed ID: 11032702
[TBL] [Abstract][Full Text] [Related]
19. Safety, tolerability, and single- and multiple-dose pharmacokinetics of piperaquine phosphate in healthy subjects.
Ahmed T; Sharma P; Gautam A; Varshney B; Kothari M; Ganguly S; Moehrle JJ; Paliwal J; Saha N; Batra V
J Clin Pharmacol; 2008 Feb; 48(2):166-75. PubMed ID: 18199893
[TBL] [Abstract][Full Text] [Related]
20. Human pharmacology of the methamphetamine stereoisomers.
Mendelson J; Uemura N; Harris D; Nath RP; Fernandez E; Jacob P; Everhart ET; Jones RT
Clin Pharmacol Ther; 2006 Oct; 80(4):403-20. PubMed ID: 17015058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
